BIG PHARMA'S NOT THE CASH COW IT WAS—TIME FOR INVESTORS TO EXIT

Investor returns are on the line

BIG PHARMA OWNS NOTHING BUT PATENTS

In this article Taking Over Big Pharma Plants, we get a flavour for the scale of outsourcing Big Pharma had been cracking on with:

“AstraZeneca intends to outsource all its active pharmaceutical ingredient (API) production over the next five to seven years. Bristol-Myers Squibb, GlaxoSmithKline, Merck & Co., and Pfizer …